Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events

Autor: Burda, Pavel, Hlavackova, Alzbeta, Polivkova, Vendula, Curik, Nikola, Laznicka, Adam, Krizkova, Jitka, Suttnar, Jiri, Klener, Pavel, Polakova, Katerina Machova
Zdroj: In Molecular Metabolism October 2024 88
Databáze: ScienceDirect